1-3 of 3
Danielle Schlafer
Close
Sort by
Journal Articles

Assessment of Midostaurin in Combination with Idarubicin-Based Induction Treatment in Acute Myeloid Leukemia

Julia Lee, Charlotte B Wagner, Stacy Prelewicz, Heena P Kurish, Rob Walchack, Danielle Cenin, Seema Patel, Mimi Lo, Danielle Schlafer, Belinda KT Li, R Donald Harvey, Bestis Wasef, Jian Ying, Tibor Kovacsovics
Journal: Blood
Blood (2022) 140 (Supplement 1): 3242–3243.
https://doi.org/10.1182/blood-2022-170123
Published: 2022
Journal Articles

Initial Salvage Approaches for Relapsed/Refractory Mantle Cell Lymphoma Have Comparable Response Rates, Progression-Free and Overall Survival

Sarah Caulfield, PharmD, Danielle Schlafer, Pharm D, BCOP, Jeffrey M. Switchenko, PhD MS, Irl Brian Greenwell, MD, Ashley D. Staton, MD, Kristie A. Blum, MD, Natalie Grover, MD, Steven I Park, MD, Alexey Danilov, MD PhD, Narendranath Epperla, MD, Timothy S. Fenske, MD, Mehdi Hamadani, MD, Max J Gordon, MD, Stephanie Mathews, Kelly Valla, PharmD, BCOP, Christopher Flowers, MD, Jonathon B Cohen, MDMS
Journal: Blood
Blood (2017) 130 (Supplement 1): 1505.
https://doi.org/10.1182/blood.V130.Suppl_1.1505.1505
Published: 2017
Journal Articles

Incidence and Predictors of Left Ventricular Dysfunction Among Acute Myeloid Leukemia Patients

Zakaria Almuwaqqat, MD, Manila Gaddh, MD, Danielle Schlafer, Pharm D, BCOP, Don Hutcherson, RPh, Martha L. Arellano, MD, Susmita Parashar, MD MPH, MS, Vamsi Kota, MBBS
Journal: Blood
Blood (2017) 130 (Supplement 1): 5025.
https://doi.org/10.1182/blood.V130.Suppl_1.5025.5025
Published: 2017